Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Accumulation...Reason why S&L and TPL can't
one more thought... there is nothing that says Swartz would have to convert/sell/buy all the warrants/shares.. perhaps only a certain %....  50% or 35%... letting the remainder be sucked up by retail and those companies who have purchased MMPs or plan on doing so

Ease... I respect your opinion here... I'm just looking at diff angles and speculating if it would/could be possible

and I do not believe in the' taking us private' senarios.. not when the publicly mentioned (ASM) how well longs should eventually do...

regards
Share
New Message
Please login to post a reply